Moderna Inc. has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday.
source https://www.cbc.ca/news/health/moderna-covid-vaccine-kids-study-1.5951440?cmp=rss
No comments:
Post a Comment